Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury.

Vitexin exerts cardioprotective effect on chronic myocardial ischemia/reperfusion injury in rats via inhibiting myocardial apoptosis and lipid peroxidation. Am J Transl Res (2016) 0.75

Myocardial reperfusion injury. N Engl J Med (2007) 13.41

Thrombin signalling and protease-activated receptors. Nature (2000) 9.27

A dual thrombin receptor system for platelet activation. Nature (1998) 3.96

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74

Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A (1998) 3.50

Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature (2001) 3.15

Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol (2002) 2.97

STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol (2004) 2.53

c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ Res (2005) 2.23

How the protease thrombin talks to cells. Proc Natl Acad Sci U S A (1999) 2.21

Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev (2006) 2.08

Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation (2007) 1.97

Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther (2011) 1.81

Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem (2005) 1.78

Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol (2002) 1.70

Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem (2006) 1.63

A fresh look at reperfusion injury. Cardiovasc Res (1998) 1.63

Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem (2000) 1.60

Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation (2002) 1.46

Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem (2004) 1.45

Serine proteases of the human immune system in health and disease. Mol Immunol (2010) 1.30

SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res Cardiol (2007) 1.30

Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res (2000) 1.30

Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem (2000) 1.29

The cardiovascular actions of protease-activated receptors. Mol Pharmacol (2004) 1.25

Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res (2002) 1.22

Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets. J Thromb Haemost (2004) 1.21

Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol (2001) 1.21

Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation (1995) 1.18

Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther (2007) 1.16

Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol (2002) 1.10

Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol (2004) 1.08

Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J Biol Chem (2003) 0.99

Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res (2002) 0.98

Novel mode for neutrophil protease cathepsin G-mediated signaling: membrane shedding of epidermal growth factor is required for cardiomyocyte anoikis. Circ Res (2007) 0.85

A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp Cell Res (2004) 0.81

Induction of apoptosis by thrombin in the cultured neurons of dorsal motor nucleus of the vagus. Neurogastroenterol Motil (2010) 0.78